The Mebendazole is the most commonly prescribed, FDA-approved oral medication when patients suffer from infections due to intestinal worms leading to symptoms for example diarrhoea, pain in the abdomen, in digestion & others. Introduced by the medicine maker, Kachhela Medex with the active substance, Mebendazole, it is an anti-helminthic drug, most commonly recommended for treating the parasitic infections taking place due to the worms, subsiding and feeding on the body of the host causing comfort and weakness. 

The generic Mebendazole has dual usage in showing efficacy across multiple cancers for example: colon, brain tumor, breast, pancreatic, ovarian, thyroid cancer, glioblastoma multiforme, medulla blastoma, and other categories. The Mebentel Mebendazole is a repurposed drug with application in oncology and it is found to carry out the inhibition of the cancerous cells growth, and migrations along with the metastasis synthesis of the adrenocortical carcinoma.